Bottom line
TECY vs BIOY: the short answer
TECY (GraniteShares YieldBOOST Technology ETF) and BIOY (GraniteShares YieldBOOST Biotech ETF) have nearly the same top holdings — their top 25 positions are about 95% the same by weight.
Both charge the same expense ratio (1.18%).
Updated Nov 19, 2026
TECY vs BIOY side by side
| TECY | BIOY | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Graniteshares | Graniteshares |
| Category | Core / Intermediate Bond | Core / Intermediate Bond |
| Expense ratio | 1.18% | 1.18% |
| Annual cost per $10k | $118 | $118 |
| 10-yr cost on $10k (prospectus) | $9,115 | $9,178 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | — | — |
| 5-yr return (annualized) | — | — |
| 10-yr return (annualized) | — | — |
| Best quarter | — | — |
| Worst quarter | — | — |
| Net assets (fund) | $685.1K | $693.2K |
| Number of holdings | 3 | 3 |
| Portfolio turnover | — | — |
| Returns as of | — | — |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
3 of TECY's top 3 holdings also appear in BIOY's top 3.
| Holding | TECY | BIOY |
|---|---|---|
| Treasury Bill | 57.70% | 57.03% |
| The Options Clearing Corporation | 0.82% | -3.20% |
| The Options Clearing Corporation | -1.45% | -3.20% |
Source: SEC Form N-PORT
TECY top 10
- Treasury Bill — 57.70%
- The Options Clearing Corporation — 0.82%
- The Options Clearing Corporation — -1.45%
BIOY top 10
- Treasury Bill — 57.03%
- The Options Clearing Corporation — 1.56%
- The Options Clearing Corporation — -3.20%
FAQ
What is the difference between TECY and BIOY?
TECY (GraniteShares YieldBOOST Technology ETF) and BIOY (GraniteShares YieldBOOST Biotech ETF) have nearly the same top holdings — their top 25 positions are about 95% the same by weight. Both charge the same expense ratio (1.18%).
Which is cheaper, TECY or BIOY?
TECY has the lower expense ratio (1.18%).
Should I own both TECY and BIOY?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.